SUMMARY A method for the simple preparation ofbiotin-labelled toxoplasma antigen was used with avidin peroxidase in an IgM-capture enzyme linked immunosorbent assay (BAM-ELISA). Although the overall predictive value of a positive result was only 38%, its low-cost and 100% sensitivity makes it a very suitable screening test. Positive results can be confirmed by an alternative assay, thus providing a more economical and effective diagnostic service than either screening all sera by a commercial test or selecting sera for IgM testing.
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Tests for the presence of specific IgM, in conjunction with the Sabin-Feldman dye test' provide the basis of reference laboratory investigation for evidence of current toxoplasmosis. The dye test is labour intensive and specimens are usually screened before submission by haemagglutination, or complement fixation assays, or by enzyme immunoassays. In Scotland the low incidence of toxoplasmosis2 makes it difficult to ELISA) was initially assessed on a panel of sera of known specific IgM results. It was then evaluated as a screening test on 910 sera referred to the laboratory over four months. A panel of sera selected from patients with diseases known to produce false positive results in IgM immunoassays-namely, rheumatoid factor (RF), anti-nuclear antibody, and Paul Bunnell positive and negative sera from patients with glandular fever-like illness-were also tested.
PREPARATION OF BIOTIN-LABELLED TOXOPLASMA ANTIGEN
Toxoplasma trophozoites (RH strain) from cotton rat peritoneal exudate were washed three times with isotonic saline and resuspended in 0-1 M sodium bicarbonate/saline, pH 8-5, at a protein concentration of 10 mg/ml. Biotin (Sigma Chemicals, Poole, Dorset), as N-hydroxy succinimidobiotin (BNHS; 0 25 mg) or biotinamidocaproate N-hydroxysuccinimide (BNHSC; 0-33 mg) in 0-3 ml dimethylformamide (BDH, Glasgow), was added slowly to 1 ml of antigen.4 After one hour at room temperature the mixture was freeze-thawed twice and centrifuged at 12000 g for one hour. The pellet was further extracted with 1% sodium deoxycholate (DOC) in 0-02 M phosphate buffered saline (PBS), pH 7-2, with agitation at 45°C for four hours' and clarified at 45000 g for 20 minutes. Both supernatants were dialysed against four changes of PBS and stored in 50% glycerol at -20C. DOC extraction was the more reliable method of obtaining a product with suitable activity; likewise, BNHSC-labelling was superior, presumably because the presence of a caproate spacer reduces steric hindrance between the labelled antigen and avidin peroxidase. (table 3) . The effect oflowering the screening threshold was a doubling of the number of screen positive results. Results were also occasionally influenced by the presence of rheumatoid factor, or Paul Bunnell antibody (figure) but the BAM-ELISA titres were invariably lower than those found in cases of confirmed toxoplasmosis. Specific IgM tests have until now been used to provide definitive evidence of recent or current toxoplasmosis. The BAM-ELISA was developed to be used in parallel with IgG-ELISA as screening tests on all submitted clonal.9 Alternatively, the antigen itself may be labelled, as in the present study. It is simpler to use biotin than to label directly with peroxidase."' It is difficult to explain why rheumatoid factor and Paul Bunnell positive sera should react in the BAM-ELISA unless they contain a cross-reacting antibody of broad specificity. By raising the threshold by 70% (or 0-07 OD units), it would be possible, as in similar tests,'0 to avoid this sort of low false positive reaction. It is preferable, however, to opt for maximum sensitivity at the screening stage and make the definitive diagnosis on the basis of dye test and confirmatory IgM tests.
The biotin reagent is inexpensive to make partly because it makes use of surplus trophozoites produced for the toxoplasma dye test. It is stable at -20°C, in 50% glycerol, for at least one year. Sera could be screened at less than 5% of the cost by equivalent commercial assays. The number of commercial IgM tests could be reduced by 57% if they were selected on the basis of BAM-ELISA screen results, giving a 46% saving for the combined cost a week of screen and confirmatory IgM testing.
The BAM-ELISA can be performed in three hours in parallel with our routine IgG-ELISA screening test from the same master dilutions of patient sera representing a considerable saving of operator time and sample manipulation. Dual screening for toxoplasma IgM and IgG is now possible comparatively cheaply to non-specialised centres. The dye test is likely to remain the definitive serological test for toxoplasmosis in this country, but the high sensitivity of these two ELISA tests would guarantee a sound basis for referral of specimens.
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